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CSFP-findings in DCM will be compared with 20 controls and results from CSFP monitoring will be
related to clinical and neurophysiological findings. Arterial blood pressure will be recorded periopera-
tively and postoperatively to calculate spinal cord perfusion pressure and spinal vascular reactivity index.
Furthermore, measures of CSFP will be compared with markers of spinal cord compression by means of
MR imaging. ETHICS AND DISSEMINATION The study protocol conformed to the latest revision of
the Declaration of Helsinki and was approved by the local Ethics Committee of the University Hospi-
tal of Zurich (KEK-ZH number PB-2016-00623). The main publications from this study will cover the
CSFP fluid dynamics and pressure analysis preoperative, perioperative and postoperative correlated with
imaging, clinical scores and neurophysiology. Other publications will deal with preoperative and postop-
erative spinal perfusion. Furthermore, we will disseminate an analysis on waveform morphology and the
correlation with blood pressure and ECG. Parts of the data will be used for computational modelling of
cervical stenosis. TRIAL REGISTRATION NUMBER ClinicalTrials.gov Registry (NCT02170155).
DOI: https://doi.org/10.1136/bmjopen-2020-037332






The following work is licensed under a Creative Commons: Attribution-NonCommercial 4.0 International
(CC BY-NC 4.0) License.
Originally published at:
Zipser, Carl Moritz; Pfender, Nikolai; Spirig, Jose Miguel; Betz, Michael; Aguirre, Jose; Hupp, Markus;
Farshad, Mazda; Curt, Armin; Schubert, Martin (2020). Study protocol for an observational study
of cerebrospinal fluid pressure in patients with degenerative cervical myelopathy undergoing surgical
deCOMPression of the spinal CORD: the COMP-CORD study. BMJ Open, 10(9):e037332.
DOI: https://doi.org/10.1136/bmjopen-2020-037332
2
1Zipser CM, et al. BMJ Open 2020;10:e037332. doi:10.1136/bmjopen-2020-037332
Open access 
Study protocol for an observational 
study of cerebrospinal fluid pressure in 
patients with degenerative cervical 
myelopathy undergoing surgical 
deCOMPression of the spinal CORD: 
the COMP- CORD study
Carl Moritz Zipser   ,1,2 Nikolai Pfender,1,2 Jose Miguel Spirig,2 Michael Betz,2 
Jose Aguirre,2,3 Markus Hupp,1,2 Mazda Farshad,2 Armin Curt,1,2 Martin Schubert1,2
To cite: Zipser CM, Pfender N, 
Spirig JM, et al.  Study protocol 
for an observational study of 
cerebrospinal fluid pressure 
in patients with degenerative 
cervical myelopathy undergoing 
surgical deCOMPression of 
the spinal CORD: the COMP- 
CORD study. BMJ Open 
2020;10:e037332. doi:10.1136/
bmjopen-2020-037332
 ► Prepublication history for 
this paper is available online. 
To view these files, please visit 
the journal online (http:// dx. doi. 
org/ 10. 1136/ bmjopen- 2020- 
037332).
Received 30 January 2020
Revised 31 July 2020
Accepted 06 August 2020
1Department of Neurology 
and Neurophysiology, Balgrist 
University Hospital, Zurich, 
Switzerland
2University Spine Center, Balgrist 
University Hospital, Zurich, 
Switzerland
3Department of Anesthesiology, 
Balgrist University Hospital, 
Zurich, Switzerland
Correspondence to
Dr Carl Moritz Zipser;  
 carlmoritz. zipser@ balgrist. ch
Protocol
© Author(s) (or their 
employer(s)) 2020. Re- use 
permitted under CC BY- NC. No 
commercial re- use. See rights 
and permissions. Published by 
BMJ.
ABSTRACT
Introduction Degenerative cervical myelopathy (DCM) is 
a disabling spinal disorder characterised by sensorimotor 
deficits of upper and lower limbs, neurogenic bladder 
dysfunction and neuropathic pain. When suspected, 
cervical MRI helps to reveal spinal cord compression and 
rules out alternative diagnoses. However, the correlation 
between radiological findings and symptoms is weak. 
Cerebrospinal fluid pressure (CSFP) analysis may 
complement the appreciation of cord compression and be 
used for intraoperative and postoperative monitorings in 
patients undergoing surgical decompression.
Methods and analysis Twenty patients diagnosed with 
DCM undergoing surgical decompression will receive 
standardised lumbar CSFP monitoring immediately before, 
during and 24 hours after operation. Rest (ie, opening 
pressure, CSF pulsation) and stimulated (ie, Valsalva, 
Queckenstedt’s) CSFP—findings in DCM will be compared 
with 20 controls and results from CSFP monitoring will 
be related to clinical and neurophysiological findings. 
Arterial blood pressure will be recorded perioperatively 
and postoperatively to calculate spinal cord perfusion 
pressure and spinal vascular reactivity index. Furthermore, 
measures of CSFP will be compared with markers of spinal 
cord compression by means of MR imaging.
Ethics and dissemination The study protocol conformed 
to the latest revision of the Declaration of Helsinki and was 
approved by the local Ethics Committee of the University 
Hospital of Zurich (KEK- ZH number PB-2016-00623). 
The main publications from this study will cover the 
CSFP fluid dynamics and pressure analysis preoperative, 
perioperative and postoperative correlated with imaging, 
clinical scores and neurophysiology. Other publications will 
deal with preoperative and postoperative spinal perfusion. 
Furthermore, we will disseminate an analysis on waveform 
morphology and the correlation with blood pressure and 
ECG. Parts of the data will be used for computational 
modelling of cervical stenosis.




Degenerative cervical myelopathy (DCM) is 
a common age- related spinal cord disorder 
characterised by progressive neurological 
impairment and neuropathic pain.1 2 With an 
annual incidence of 2–6 in 100 000 people 
and 1.6 in 100 000 being surgically treated, 
these numbers are expected to increase given 
the ageing of the global population, DCM 
ranges among the most relevant degenerative 
spine disorders.3–5 Most patients are in their 
sixth decade and present with (asymmetric) 
sensorimotor and fine- motor deficits of the 
Strengths and limitations of this study
 ► This interdisciplinary study will provide the first data 
on cerebrospinal fluid pressure (CSFP) in degenera-
tive cervical myelopathy (DCM) before, during and 
after surgical decompression.
 ► There will be a multimodal DCM assessment with 
clinical scores, quantitative MR imaging, neurophys-
iology and CSFP analysis.
 ► This study is the first to perform a digitised mea-
surement and recording of CSFP and invasive arteri-
al blood pressure to derive spinal perfusion pressure 
(spinal cord perfusion pressure=mean arterial pres-
sure CSFP) in DCM.
 ► Changes in CSFP may be variable as jugular vein 
compression (Queckenstedt’s test) will be applied 
manually (by the same investigator) while a pressure 
cuff for standardisation is technically not applicable.
 ► Since lumbar CSFP analysis is an invasive technique 
with usually mild but common side effects, the ap-
plication of CSFP measurements needs to provide 
clinically relevant additional diagnostic information 
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upper extremity, gait instability, neurogenic bladder 
dysfunction, radiating burning and stabbing pain in the 
upper extremity.6 Typically, symptoms develop within 
months, with sometimes subacute aggravation in the 
natural course or acute exacerbation following trauma. 
Spinal cord compression arises from degeneration of 
facet joints and ligaments, disc disease and cervical joint 
hypermobility. On the microstructural level, segmental 
blood flow becomes increasingly restricted and microvas-
cular integrity lost, leading to a complex cascade of isch-
aemia and inflammation, and ultimately, demyelination 
and neuronal degeneration.7–9 In some cases, congenital 
disorders, for example, Down syndrome, Klippel- Feil 
syndrome and congenital cervical spine stenosis, may 
accelerate chronic degeneration.10 Cervical MRI allows 
the exclusion of differential diagnoses, it may reveal direct 
signs of myelopathy in some patients, whereas in others, 
only spinal cord compression and loss of cerebrospinal 
fluid signal (CSF) may be evident, most common at the 
levels C5–C6.11 Various descriptions for cord compression 
and for degenerative changes are used,11 12 the correlation 
to symptoms is reported to be poor by some,13 whereas 
other studies report a sufficient correlation.14 While many 
asymptomatic patients have disc bulging in cervical MRI, 
few asymptomatic patients have spinal cord compression 
or signs of myelopathy.15 Recently, more sophisticated 
MR protocols demonstrated higher spinal cord motion 
at the level of stenosis that correlated with disability.16 
Neurophysiological studies, that is, motor- evoked poten-
tial (MEP) and somatosensory- evoked potential (SEP), 
support the diagnosis and aid in the prognosis of the 
outcomes,17 and intraoperative neurophysiologic moni-
toring can be used to detect imminent spinal cord 
damage.18 Contact heat- evoked potentials (CHEPs) may 
increase the sensitivity of conventional neurophysiology 
assessments for spinal conduction deficits.19 Patients with 
DCM may be treated with conservative management or 
surgical decompression.20 21 In patients with moderate or 
severe disability, current guidelines recommend surgical 
decompression, with the goal of symptom remission and 
minimum goal of halting disease progression.22 23 The 
decision in favour of surgery over conservative mainly 
depends on the clinical symptoms and progression and 
it does not require signs for myelopathy in the MRI.24 
Dorsal and ventral surgical techniques can be chosen, the 
method depends on the affected structures.25–29 Periop-
erative complications may occur in 11%–38% of patients, 
with higher risk in elder patients with two- stage surgery.30 
Symptoms have a relevant impact on quality of life31 and 
improve with timely surgical decompression.32 Outcomes 
are generally worse in elderly patients with more severe 
impairment and longer symptom duration prior to 
decompression.33 Therefore, awareness for symptom 
progression and early diagnosis of DCM is important.34
Before the introduction of CT and MRI, cerebrospinal 
fluid pressure analysis (CSFP) was a common method to 
quantify spinal cord compression.35–37 Applying jugular 
vein compression during lumbar puncture—termed 
Queckenstedt’s test—leads to an increase in CSFP that 
is impaired or absent in spinal canal stenosis.38 39 Also 
with changing head positions during vein compression, 
the sensitivity for spinal stenosis may be increased.38 40 41 
The same authors have demonstrated normalised CSFP 
following decompression in suspected spinal stenosis. 
MRI to confirm stenosis was not available at that time, 
however. One study has demonstrated spinal block with 
CSFP analysis in patients with Arnold- Chiari malfor-
mation, which was relieved following laminectomy.42 In 
acute spinal cord injury (SCI), it has been found recently 
that CSFP is altered and restitutes following decompres-
sion.43 Furthermore, a multicentre prospective study esti-
mated spinal cord perfusion pressure (SCPP) from CSFP 
and mean arterial pressure and found higher SCPP to 
correlate with improved clinical outcome.44 From studies 
that measure intraspinal pressure (ISP) in acute SCI, the 
spinal vascular reactivity index (sPRx) was calculated, 
indicating impaired autoregulation in some patients.45 All 
these findings support the translation of CSFP measure-
ments to DCM.
In a pilot study, we confirmed feasibility and safety of 
intraoperative CSFP monitoring at our institution (in 
press). We were able to demonstrate responsive Quec-
kenstedt’s test postdecompression in two patients. Base-
line values were not acquired in the pilot study and are 
subjected to the present study. The optimum SCPP, calcu-
lated from overnight recordings of invasive arterial blood 
pressure (ABP) strongly resembled values obtained in 
acute SCI patients after decompression.44
Aims and objectives
We aim to explore the potential of dynamic CSFP analysis 
for intraoperative and postoperative neuromonitoring 
of decompressive surgery in DCM. We aim to further 
expand the current knowledge on DCM pathophysiology. 
The following objectives would allow the achievement of 
these aims:
The primary objective is evaluating the preoperative, 
intraoperative and postoperative fluid dynamics of CSFP, 
including spontaneous pulsations, opening pressure, 
reaction to jugular vein compression in neutral head posi-
tion (Queckenstedt’s test) and Valsalva manoeuvre.
Secondary objectives are the relation of pressure param-
eters with clinical and imaging parameters:
1. Investigating CSFP—changes related to perioperative 
and postoperative complications, for instance, spinal 
cord swelling and haemorrhage.
2. Correlating preoperative Queckenstedt’s test and 
clinical data (neurological deficits, duration of symp-
toms, modified Japanese Orthopedic Association scale 
(mJOA), neurophysiology examinations).
3. Correlating CSFP and structural MRI parameters (spi-
nal cross- section and diameter).
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5. Calculating group differences of Queckenstedt’s test 
and Valsalva manoeuvre between control participants 
and patients with DCM.
6. Investigating CSFP—changes related to body position.
Tertiary objectives are the investigation of perfusion 
parameters:
1. Determining optimum postoperative SCPP.
2. Investigating correlations between postoperative sPRx 
and CSFP.
3. Calculating differences between perioperative and 
postoperative SCPP.
4. Exploring temporal correlations between pressure 
peaks in CSFP, ABP and ECG.
Our study is novel in several regards. First, previous 
studies seek to detect spinal compression at times when 
MRI was not available, whereas this study investigates the 
relation of structural cord compression and CSF abnor-
malities. Second, this will be the first study in spinal 
stenosis that uses the advantages of digitalised measuring 
and recording. For instance, our approach allows the anal-
ysis of waveforms (signals and fast Fourier transformation 
(FFT) and correlation to ABP as well as the estimation of 
SCPP. At last, this study first records CSFP during opera-
tion and 24 hours after and herewith evaluates its value 
as a monitoring tool. Our results may increase the phys-
iological understanding of DCM and cerebrospinal fluid 
dynamics in general.
METHODS AND ANALYSIS
Study setting and eligibility criteria
This study will be a single- centre prospective observa-
tional study conducted at The University Spine Center 
Zurich, located at the Balgrist University Hospital, which 
provides highly specialised treatment for SCI. Pilot 
data were acquired prior to this study to establish the 
methodology, refine the study protocol and ensure the 
cooperation between disciplines involved (neurologists, 
spine surgeons, anesthesiologists). Enrolment for the 
study started in December 2019. Reporting followed the 
STrengthening the Reporting of OBservational studies in 
Epidemiology (STROBE) statement, where applicable in 
the reporting of a study protocol.46
Inclusion criteria are clinical symptoms of DCM, radio-
graphic evidence of cervical spinal cord compression, 
eligibility for surgical decompression, age between 18 and 
80 years, written informed consent (IC) and eligibility for 
CSFP monitoring. Exclusion criteria are contraindica-
tions to MRI, for example, cardiac pacemaker, pregnancy 
(in case of uncertainty, subjects will undergo urine and/or 
blood testing) and psychiatric disorders that alter ability 
to give IC or potentially interfere with the measurements.
Control participants should be age- matched and gender- 
matched and do not have clinical symptoms suggestive of 
cervical stenosis. They receive bedside lumbar puncture 
for diagnostic purpose other than stenosis. for example, 
suspected demyelinating disease and inflammatory 
polyneuropathy and CSFP measurement as part of stan-
dard procedure.
A total of 20 patients with DCM and 20 patients of 
control participants will be included in this study, a 
number was chosen based on the previous CSFP studies 
in compressive spinal cord disorders. To our best knowl-
edge, three studies compared Queckenstedt’s test before 
and after decompression by two separate lumbar punc-
tures. One study reported six patients with spinal block 
who underwent decompressive spine surgery, where 
cord compression was confirmed intraoperatively.40 
Postoperative lumbar puncture revealed normal results. 
Another study reported spinal block in two patients who 
later underwent decompressive surgery.47 Postoperative 
lumbar puncture showed normal test results. For studying 
the mechanisms of CSFP abnormalities in Arnold- Chiari 
malformation preoperative and postoperative, lumbar 
puncture was performed in nine patients. In all patients, 
preoperative results were abnormal and normalised after 
surgery.42 Although pathology is unlike that suspected in 
DCM, the number of subjects needed to obtain conclu-
sive results should be similar. Our study is not designed 
and powered to evaluate the relationship between moni-
toring results and outcome but as a purely observational 
study that intends to evaluate CSFP as a potential periop-
erative monitoring tool.
Ethics and dissemination
The study protocol conformed to the latest revision of 
the Declaration of Helsinki and was approved by the local 
Ethics Committee of the University Hospital of Zurich. 
The main publications from this study will cover the 
CSFP fluid dynamics and pressure analysis preoperative, 
perioperative and postoperative correlated with imaging, 
clinical scores and neurophysiology. Other publications 
will deal with preoperative and postoperative spinal 
perfusion. Furthermore, we will disseminate an analysis 
on waveform morphology and the correlation with blood 
pressure and ECG. Parts of the data will be used for 
computational modelling of cervical stenosis.
Clinical and neurophysiological parameters
In all patients admitted for elective surgery, the Spinal 
Cord Independence Measure, mJOA, American Spinal 
Injury Association Impairment Scale and visual analogue 
scale for pain will be obtained. Additionally, following 
binary variables will be noted: presence of bladder 
dysfunction and spasticity. At baseline, a standard set of 
neurophysiological parameters will be collected: MEP 
from the lower limbs, tibial F- waves and tibial SEP. Central 
motor conduction time to the lower extremities will be 
calculated from F- waves and lumbar stimulation.48 In 
patients with contraindications to transcranial magnetic 
stimulation, for example, cochlear implants and seizures, 
MEP will not be performed.49 Additional neurophysiology 
will be acquired if requested by the investigators. MEP 
will be acquired with Magstim-200 stimulator connected 
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Wales, UK) and SEPs with SEPs and F- wave examina-
tion with Dantec Keypoint neurophysiology equipment 
(Natus Medical, San Carlos, USA). In patients scheduled 
for elective surgery, CHEPs will be acquired (Pathway, 
Medoc, RamatYishai, Israel). All patients will be followed 
up 6 months after surgery for neurological examination.
We expect surgical decompression to be performed 
within a few days after the first consultation in some 
patients, while other operations are planned weeks 
before. To account for emergent clinical cases, we defined 
a minimum data set for inclusion, consisting of preoper-
ative, intraoperative and postoperative clinical examina-
tions, CSFP/ABP monitoring, cervical MRI and mJOA.
Imaging
All patients who are primarily referred to our Spine 
Center, which is the majority of patients, will undergo a 
3T cervical MRI scan (MAGNETOM SkyraFit, Siemens 
Healthcare, Erlangen; MAGNETOM Prisma, Siemens 
Healthcare, Erlangen) including sagittal and axial stan-
dard clinical T2w sequences. In patients who underwent 
recent external MRI, 1.5T cervical is also accepted, if 
required sequences are included, to avoid repetitive diag-
nostics. When correlating MRI and CSFP parameters, 
differences in signal- to- noise ratio between 1.5 and 3T 
will be considered, respectively. Common quantitative 
measurements for spinal cord compression are going to 
be calculated.12 For characteristic MR findings in DCM, 
please refer to figure 1.
Lumbar catheter insertion and CSFP data recording
For the purpose of measuring CSFP, a lumbar catheter 
(Neuromedex Lumbalkatheter 4.5F) will be inserted 
about 20 cm into the spinal canal through a 14- gauge 
Tuohy needle in lateral decubital position after narcosis, 
immediately prior to surgery. Then, it will be connected 
to an analogue digital pressure converter (Neuromedex 
VentrEX), and the digitised signal will be linked to a Philips 
X2- Pat.Interface+MX 700 Monitor, connected to online 
recording software ICM+ (University of Cambridge). The 
correct catheter placement confirmed online by clear 
response to coughing, respiratory modulation, CSF pulsa-
tion or ventilatory- induced Valsalva manoeuvre. The ABP 
will be recorded concomitantly during and after surgery 
from a radial artery catheter kept at the same horizontal 
level as the injured segment of the spinal cord. Addi-
tionally, three- lead electrocardiograph will be recorded 
(ECG).
Based on the established procedures, calculations 
are as follows: the MAP is calculated from the systolic 
and diastolic ABP. Then, CSFP and MAP are employed 
to calculate the SCPP (MAP- CSFP). To further charac-
terise dynamics of spinal perfusion, the sPRx, a measure 
of spinal cord vascular reactivity will be calculated from 
the correlation coefficient between mean CSFP and MAP. 
Before decompression, intraoperatively, we will record 
CSFP and ABP for 30 min. After surgery, we will record 
CSFP and ABP up to 24 hours. To calculate perfusion 
parameters, integrated tools from ICM+ software and 
established analytical procedures will be used.45 Perfusion 
parameters will not be obtained in control participants. 
Individual and pooled optimum postoperative SCPP 
(in mm Hg) will be calculated over 6 hours (overnight), 
estimated by plotting sPRx against SCPP, defining nadir 
of sPRx as optimum. Additionally, sPRx will be plotted 
against CSFP to investigate autoregulation capacity.
CSFP examinations
A standard operating procedure guides the preopera-
tive and postoperative manoeuvres. First, opening pres-
sure will be recorded, followed by Queckenstedt’s test in 
neutral head position (figure 2 shows characteristic find-
ings in the presence of spinal stenosis and normal find-
ings from our recordings). Queckenstedt’s test will be 
performed in lateral decubital position before entering 
the operation room by applying firm manual pressure on 
both jugular veins until carotid pulsation was felt for about 
10 s. Previous studies reported higher sensitivity of Quec-
kenstedt’s test in different head postures, that is, neutral, 
flexion and extension.38 40 41 For safety concerns, we will 
not perform these manoeuvres. Therefore, spinal block 
might be underdetermined in this cohort. During surgery, 
CSFP will be recorded without manoeuvres. Intraopera-
tive recording will be performed in supine or prone posi-
tion, depending on dorsal or ventral surgical approach. 
After surgery, depending on the time required to extu-
bate and to transfer to intensive care unit, Queckenstedt’s 
test will be performed within 6 hours and >12 hours after 
surgery. Within these time windows, Valsalva manoeuvre 
will be performed additionally, if the postoperative level 
of consciousness allows. Queckenstedt’s test >12 hours 
after surgery will be performed in supine and lateral 
decubital positions. Queckenstedt’s test will be evaluated 
with regards to maximum amplitude, steepness of slope 
and return to baseline and frequency spectrum FFT. Inde-
pendent from the manoeuvres, CSFP, ECG and ABP will 
Figure 1 Cervical sagittal and axial T2w MRI sequences in a 
representative patient with degenerative cervical myelopathy 
showing narrowed spinal canal, hyperintense T2w lesions, 
effacement of the cerebrospinal fluid signal, impression of the 
spinal cord, and reduced diameter (91.55 mm2) at the level of 
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be recorded continuously up to 24 hours after operation. 
CSFP examinations will not be performed at follow- up.
To address potential confounding factors that may 
affect the CSFP analysis, following analyses will be 
performed. We will compare intraoperative pulsation in 
patients with dorsal versus ventral surgical approach, that 
is, prone versus supine body position. Also, postoperative 
Queckenstedt’s test results >12 hours in lateral decubital 
versus supine body position will be compared.
In controls, lumbar puncture will be performed in 
lateral decubital position. The pressure transducer will be 
directly connected to a 20–22- gauge Sprotte or Quincke 
needle and manoeuvres performed analogously to 
patients with DCM.
Data analysis
CSFP- related data are in part purely qualitative, for 
example, wave morphology, whereas other data are 
binary, for example, abnormal versus normal reac-
tion after jugular vein compression or continuous, for 
example, CSFP maximum during Valsalva, jugular vein 
compression and opening pressure. For the purpose of 
evaluating preoperative, intraoperative and postoperative 
pressure indices, descriptive and repeated measurement 
analysis of variance (ANOVA) including post hoc tests 
with Bonferroni correction will be performed. For contin-
uous data, general descriptive statistics will be reported as 
means and SD. Normal distribution of data will be evalu-
ated with the Kolmogorov- Smirnov test. In case of normal 
distribution, Student’s t- test, otherwise, non- parametric 
tests will be used to test for group differences (age, sex, 
pressure indices), maximum amplitudes of Valsalva 
manoeuvre, and to test preoperative and postopera-
tive maximum Queckenstedt’s maximum amplitudes in 
different body positions. Multiple linear regression anal-
ysis will be applied to track the interaction with MAP and 
the correlation to MRI, clinical, and neurophysiological 
data. A p value of <0.05 will be considered significant. All 
analyses will be computed with the Statistical Package for 
Social Sciences (SPSS, V.25).
Methodological issues I: CSFP analysis in spinal stenosis
This study has the potential to significantly increase our 
knowledge on the physiology of DCM and it potentially 
introduces a method for monitoring intraoperative and 
postoperative complications. The evaluation of CSFP and 
especially Queckenstedt’s test has a longstanding tradi-
tion in the diagnosis of spinal neurological disorders. 
When reviewers reported about low sensitivity of CSFP 
for spinal obstruction compared with myelography and 
intraoperative findings, they mostly referred to lesions at 
or above the foramen magnum,50 which is indeed not an 
ideal subject CSFP analyses.51 Despite all obstacles,39 CSFP 
analysis was considered a useful method for the diagnosis 
of cervical obstruction before the introduction of myelog-
raphy. With increasingly sophisticated imaging methods, 
cervical MRI being considered the gold- standard nowa-
days, researchers lost interest in CSFP analysis in cervical 
stenosis. But what can CSFP analysis contribute to the 
field today? CSFP analysis allows a direct assessment of 
the CSF compartment and the manipulation of cerebro-
spinal fluid flow to test local fluid dynamics. The correla-
tion between clinical symptoms and severity of cord 
compression is controversially debated, with evidence for 
sufficient correlation14 and also reports of poor correla-
tion between degree of spinal cord compression as deter-
mined in the conventional MRI and individual symptom 
severity.13 The physiological understanding of these obser-
vations is limited. To overcome this limitation, advanced 
MRI techniques—aimed at CSF properties—have been 
developed. In DCM, velocity and flow of CSF have been 
shown to be decreased,52 53 and these advanced imaging 
techniques might be worthwhile additions to routine 
preoperative investigations. The same is valid for spinal 
diffusion tensor imaging.54 However, advanced MRI tech-
niques cannot substitute for CSFP analysis because they 
measure the flow and velocity only in the resting state, 
whereas invasive CSFP recordings can be manipulated 
during measurements. Most importantly, with MRI, an 
intraoperative monitoring is not feasible and acute post-
operative changes are difficult to detect, due to oedema 
and hardware inserted during the operation.
In summary, CSFP analysis may reveal severe func-
tional spinal obstruction in mild structural compression 
and therefore complement the diagnostic assessment. 
Figure 2 Bedside CSFP recordings (60 s, x- axes) of 
CSFP in mm Hg (y- axes) in a patient without (HC; left) 
and with cervical stenosis (DCM; right). Blue arrows 
mark the onset of provocation manoeuvres with jugular 
vein compression (Queckenstedt’s test; upper rows) and 
Valsalva manoeuvre (lower rows), respectively, represented 
by the pictograms. Upper rows: without stenosis, CSFP 
was pulsatile (corresponding heart rate around 80 pulses/
minute) and rapidly increased from baseline pressure of 12 
mm Hg to 27 mm Hg during Queckenstedt’s test. In the 
presence of stenosis, cardiac pulsations were absent, but 
the signal was still modulated with respiration (corresponding 
respiratory rate about 18–20/min). Queckenstedt's test 
was not responsive, that is, CSFP did not react to jugular 
vein pressure, indicating spinal block. Lower rows: during 
Valsalva maneuver CSFP increased in both participants to 
values well above 50 mm Hg. This indicates that different 
physiological mechanisms are responsible for pressure 
increase in Queckenstedt’s test and Valsalva manoeuvre. Due 
to more pressure increase with Valsalva test stenosis can be 
overcome and therefore response is positive in the patient 
with DCM as well. CSFP,cerebrospinal fluid pressure; DCM, 
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Patients benefit from this approach because it may help 
discriminate patients who have functionally relevant 
spinal obstruction and thus may be eligible for operation 
from those who can be followed up and managed conser-
vatively. Due to its invasive nature, CSFP monitoring is 
not meant to substitute MRI, but to supplement imaging 
in some cases. For intraoperative monitoring, it could be 
combined with established technologies, for example, 
intraoperative ultrasound.55
Methodological issues II: the evaluation of SCPP with CSFP
The evaluation of spinal cord perfusion is challenging. Due 
to the thin calibre of the widely distributed spinal vessels, 
conventional strategies, to assess perfusion, such as MR-/
CT- angiography and neurovascular ultrasound, are not 
applicable. Direct invasive measurement in segmental 
arteries has been performed previously, but it is very chal-
lenging and restricted to the intraoperative setting and 
therefore does not allow postoperative monitoring.56 Alter-
natively, the correlation between MAP and lumbar CSFP 
has been proposed to estimate spinal cord perfusion in 
traumatic injury.43 Animal experiments have indeed proved 
that CSFP and spinal cord perfusion are interrelated. When 
CSF was drained in mongrel dogs at the cisterna magna 
during thoracic aorta occlusion, spinal cord blood flow 
(SCBF) increased.57 A study which chose the lumbar CSF 
route in dogs has shown decreasing SCBF when mock CSF 
was infused,58 a finding that could be replicated in the same 
canine model from another group.59 Thus, the calculation 
of SCPP from MAP and lumbar CSFP appears valid for the 
estimation of postoperative SCBF.
Investigations of SCPP are relevant for defining 
optimum intraoperative and postoperative blood pres-
sure values. Current guidelines recommend MAP goals of 
85–90 mm Hg in acute SCI, as higher MAP correlates with 
better neurological outcome.60 61 However, studying MAP 
does only provide an indirect mean of spinal cord perfu-
sion. In acute SCI, therefore, studies were conducted to 
measure SCPP, while in DCM, the spinal perfusion has 
not been investigated in vivo yet. Two approaches were 
applied in traumatic SCI: with subdural probes at the level 
of injury, the group of Papadopoulos has demonstrated 
that ISP is elevated at the site of acute traumatic injury, 
resulting in reduced perfusion and impaired haemody-
namic autoregulation, potentially causing a worse neuro-
logical outcome.45 62–64 With lumbar catheters, the group 
of Kwon has demonstrated that SCPP >50 mm Hg is a 
strong predictor for better neurological outcome after 
acute SCI.44 Although reasonable arguments in favour 
of subdural at- level measurements exist,65 we chose the 
lumbar estimation for this study for two reasons. First, 
the dura is not injured in DCM and when introducing a 
subdural probe, the dura must be opened, and second, 
because there is substantial evidence on lumbar CSFP 
analysis that we aim to extend.
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Data from pressure analysis may be shared on reasonable 
request.
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